| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57c169080d3a0c28075d4b41ef8b434e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 |
| filingDate |
2000-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a229ba881f20b40bcf9fba9a5568816b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_927dfc82a7e72ceec87dbbdd202d7944 |
| publicationDate |
2002-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1206313-A1 |
| titleOfInvention |
Preparation of a therapeutic composition |
| abstract |
Product R, a novel therapeutic composition for treating viral infections and stimulating the immune system, comprises nucleotides and peptides that have molecular weights not more than 14 KDa and substantially not more than 8 KDa. The composition has a light absorption spectrum with typical absorption ratios of 1.998 at 260nm/280nm and 1.359 at 260nm/230nm. |
| priorityDate |
1999-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |